LPL Financial’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.49M Buy
225,438
+24,005
+12% +$371K ﹤0.01% 2593
2025
Q1
$3M Buy
201,433
+14,781
+8% +$220K ﹤0.01% 2557
2024
Q4
$2.47M Buy
186,652
+3,564
+2% +$47.2K ﹤0.01% 2663
2024
Q3
$2.6M Buy
183,088
+11,538
+7% +$164K ﹤0.01% 2458
2024
Q2
$2.22M Sell
171,550
-111
-0.1% -$1.44K ﹤0.01% 2492
2024
Q1
$2.38M Buy
171,661
+51,029
+42% +$709K ﹤0.01% 2380
2023
Q4
$1.72M Buy
120,632
+13,346
+12% +$190K ﹤0.01% 2535
2023
Q3
$1.66M Sell
107,286
-870
-0.8% -$13.5K ﹤0.01% 2444
2023
Q2
$1.7M Buy
108,156
+3,153
+3% +$49.5K ﹤0.01% 2378
2023
Q1
$1.73M Buy
105,003
+36,850
+54% +$607K ﹤0.01% 2262
2022
Q4
$1.06M Buy
68,153
+54,384
+395% +$848K ﹤0.01% 2587
2022
Q3
$179K Buy
13,769
+541
+4% +$7.03K ﹤0.01% 3947
2022
Q2
$186K Sell
13,228
-531
-4% -$7.47K ﹤0.01% 3950
2022
Q1
$197K Sell
13,759
-8,316
-38% -$119K ﹤0.01% 3819
2021
Q4
$301K Sell
22,075
-14,586
-40% -$199K ﹤0.01% 3669
2021
Q3
$601K Buy
36,661
+1,290
+4% +$21.1K ﹤0.01% 3036
2021
Q2
$595K Buy
35,371
+3,301
+10% +$55.5K ﹤0.01% 2992
2021
Q1
$586K Buy
32,070
+3,926
+14% +$71.7K ﹤0.01% 2879
2020
Q4
$512K Sell
28,144
-1,970
-7% -$35.8K ﹤0.01% 2725
2020
Q3
$537K Sell
30,114
-3,462
-10% -$61.7K ﹤0.01% 2384
2020
Q2
$602K Sell
33,576
-536
-2% -$9.61K ﹤0.01% 2213
2020
Q1
$518K Buy
34,112
+18,089
+113% +$275K ﹤0.01% 2068
2019
Q4
$316K Buy
16,023
+4,544
+40% +$89.6K ﹤0.01% 2720
2019
Q3
$197K Buy
11,479
+1,344
+13% +$23.1K ﹤0.01% 3001
2019
Q2
$179K Sell
10,135
-22,664
-69% -$400K ﹤0.01% 3033
2019
Q1
$668K Buy
+32,799
New +$668K ﹤0.01% 1960